Prevention of Posttraumatic Osteoarthritis After Acute Intraarticular Fractures
Inhibition of Inflammation for Prevention of Posttraumatic Osteoarthritis After Acute Intraarticular Fractures
1 other identifier
observational
62
1 country
1
Brief Summary
Intra-articular fracture is a very common fracture. The only method to treat these fractures is surgery with plate and screws followed by rehabilitation. Even though the surgeons do their best to restore the anatomy, up to 40 percent of the patients develop osteoarthritis after 10 years. Previous research has shown that immediately after fracture in the joint, the body starts an inflammatory response and activates a series of biomarkers inside the joint space. Some of these biomarkers are believed to break down the cartilage resulting in development of osteoarthritis, despite surgical treatment. Currently it is still unknown, which biomarkers are activated in the joint space, and how we can stop their deleterious action in order to prevent cartilage degradation. The purpose of this project is to identify the biomarkers in the joint space after an intra-articular ankle fracture and to evaluate how these biomarkers affect the short- and mid-terms clinical outcomes. As secondary outcomes we evaluate how fracture classification and fracture reduction affect clinical outcomes and physical activity after surgery.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started Oct 2017
Longer than P75 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
October 31, 2017
CompletedFirst Submitted
Initial submission to the registry
November 9, 2018
CompletedFirst Posted
Study publicly available on registry
December 10, 2018
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 31, 2022
CompletedDecember 10, 2018
December 1, 2018
3.2 years
November 9, 2018
December 5, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Concentration of cytokines in fracture ankle versus non-fracture ankle
Multiplex ELISA kits will be use to identify cytokines in both ankles. Cytokines with significant difference will be identified.
During surgery
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (AOFAS)
The identified cytokines in the fracture ankle (fracture non fracture ratio above 2.0) will be coupled to the scores of functional foot score (AOFAS), The American Orthopedic Foot and Ankle Score, includes pain, function, alignment, for AOFAS calculation the subscores are added, ranges between 0 (worst) and 100 (best) points
12 months after surgery
Secondary Outcomes (8)
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (FFI.DK)
12 months after surgery
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (EQ5D-5L)
12 months after surgery
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (VAS-score)
12 months after surgery
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (Swelling)
12 months after surgery
Cytokines (identified in primary outcome 1) correlation with clinical outcomes (FFI.DK)
3 months after surgery
- +3 more secondary outcomes
Other Outcomes (12)
Correlation between fracture classification and clinical outcomes (AOFAS)
12 months after surgery
Correlation between fracture classification and clinical outcomes (FFI.DK)
12 months after surgery
Correlation between fracture classification and clinical outcomes (EQ5D-5L)
12 months after surgery
- +9 more other outcomes
Eligibility Criteria
All patients hospitalize in Odense University, Svendborg (31th. Oct. 2017-Jan. 2019) will be screened for eligibility.
You may qualify if:
- Age between 18 and 65 years
- Existence of an acute fracture involving the ankle (location AO43,AO44) requiring open or closed reduction and internal or external fixation within 14 days
- Being able to read and understand Danish
- Informed consent
You may not qualify if:
- Open fractures
- Associated arterial and nerve injuries
- Multiple injured patients with an Injury Severity Score \>16
- Primary or secondary infections
- Injuries associated to a Charcot foot
- Signs of existing OA on X-ray
- Others
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- University of Southern Denmarklead
- University of Freiburgcollaborator
- Odense University Hospitalcollaborator
- The Danish Rheumatism Associationcollaborator
- Hartmann Fondencollaborator
- AP Møller Fondcollaborator
Study Sites (1)
The Orthopaedic Research Unit
Odense, 5000, Denmark
Related Publications (2)
Pham TM, Kristiansen EB, Frich LH, Lambertsen KL, Overgaard S, Schmal H. Association of acute inflammatory cytokines, fracture malreduction, and functional outcome 12 months after intra-articular ankle fracture-a prospective cohort study of 46 patients with ankle fractures. J Orthop Surg Res. 2021 May 25;16(1):338. doi: 10.1186/s13018-021-02473-8.
PMID: 34034772DERIVEDPham TM, Frich LH, Lambertsen KL, Overgaard S, Schmal H. Elevation of Inflammatory Cytokines and Proteins after Intra-Articular Ankle Fracture: A Cross-Sectional Study of 47 Ankle Fracture Patients. Mediators Inflamm. 2021 Jan 8;2021:8897440. doi: 10.1155/2021/8897440. eCollection 2021.
PMID: 33505222DERIVED
Biospecimen
Whole blood (5.0-20.0 ml) Synovial Fluids (1.0-10.0 ml) from both ankle joints
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Søren Overgaard, Professor
The Orthopaedic Research Unit
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
November 9, 2018
First Posted
December 10, 2018
Study Start
October 31, 2017
Primary Completion
December 31, 2020
Study Completion
December 31, 2022
Last Updated
December 10, 2018
Record last verified: 2018-12